Literature DB >> 31036363

Integrated liquid chromatography-mass spectrometry and nuclear magnetic resonance spectra for the comprehensive characterization of various components in the Shuxuening injection.

Shuting Yu1, Jing Li2, Liang Guo3, Caixia Di3, Xuemei Qin4, Zhenyu Li5.   

Abstract

Shuxuening injection (SXNI) is made from the extract of Ginkgo biloba, and used for curing coronary heart disease, stenocardia and cerebral vasospasm. However, the flavonoids and terpene trilactones (TTLs) only account for about 30% of the dry weight of SXNI according to the current quality control standard. Thus, systematic investigation of the chemical composition of SXNI is needed to guarantee the drug safety. In this study, the integral approach of ultra high performance liquid chromatography-Q Exactive hybrid quadrupole-orbitrap high resolution accurate mass spectrometry (UHPLC-Q-Orbitrap HRMS) and nuclear magnetic resonance (NMR) techniques, combining with the solvent partition, were used for identifying the phytochemical compounds in SXNI. The NMR analysis revealed the possible structure types based on the characteristic chemical shifts, coupling constants, and peak shape, which gave the clues for the further UHPLC-Q-Orbitrap HRMS analysis of previously unknown or uncatalogued compounds. The characteristic ions and structural network of flavonoids and TTLs were generated and used in the UHPLC-Q-Orbitrap HRMS based structure identification. Only 72 compounds could be identified by the direct UHPLC-Q-Orbitrap HRMS analysis of SXNI, while this systematic strategy led to the identification of 133 compounds, which included 73 flavonoids, 5 biflavone, 6 proanthocyanidin, 14 TTLs, 6 fatty acids, 5 fatty amides, 12 organic acids, 1 amino acid, 3 excipients, 2 saccharides and 6 other components. In addition, the presence of steroids and triglycerides were also suggested by NMR. The absence of toxic components in SXNI was also confirmed. In addition, the NMR spectrum also revealed some unknown signals, which need to be further identified. This approach was proved to be useful for the rapid and effective identification of various compounds in the TCM preparations.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemical composition; Ginkgo biloba; NMR; Shuxuening injection; UHPLC-Q-Orbitrap HRMS

Mesh:

Substances:

Year:  2019        PMID: 31036363     DOI: 10.1016/j.chroma.2019.04.008

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Characterization of multiple chemical components of GuiLingJi by UHPLC-MS and 1H NMR analysis.

Authors:  Jingchao Shi; Xiaoxia Gao; Airong Zhang; Xuemei Qin; Guanhua Du
Journal:  J Pharm Anal       Date:  2021-09-25

2.  Macromolecular substances as a dangerous factor in traditional Chinese medicine injections were determined by size-exclusive chromatography.

Authors:  Yue Li; Jinlian Duan; Heng Xia; Bin Shu; Weigang Duan
Journal:  Toxicol Res (Camb)       Date:  2020-05-21       Impact factor: 3.524

3.  LC-MS analysis of Myrica rubra extract and its hypotensive effects via the inhibition of GLUT 1 and activation of the NO/Akt/eNOS signaling pathway.

Authors:  Jing Li; Huiling Wang; Jian Li; Yonggang Liu; Hong Ding
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

4.  Blending Technology Based on HPLC Fingerprint and Nonlinear Programming to Control the Quality of Ginkgo Leaves.

Authors:  Zhe Liu; Guixin Li; Yu Zhang; Hongli Jin; Yucheng Liu; Jiatao Dong; Xiaonong Li; Yanfang Liu; Xinmiao Liang
Journal:  Molecules       Date:  2022-07-25       Impact factor: 4.927

Review 5.  A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine.

Authors:  Haiyu Xu; Yanqiong Zhang; Ping Wang; Junhong Zhang; Hong Chen; Luoqi Zhang; Xia Du; Chunhui Zhao; Dan Wu; Feng Liu; Hongjun Yang; Changxiao Liu
Journal:  Acta Pharm Sin B       Date:  2021-03-20       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.